It concludes that alterations in the expression of genesinvolved in the anabolic and/or catabolic process, even in adjacent healthy tissue, may slow down the healing process of thedamaged tissue or cause undesired cell differentiation.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:AIM: To evaluate the effects of pre- and intra-operatively administered daptomycin (DAP) on the intact human primary intervertebraldisc tissue cells.MATERIAL and METHODS: Primary cell cultures were established using tissues obtained through decompressive laminectomy,traumatic intervertebral disc herniation excision, and posterior transpedicular stabilization.
📊
Temel Bulgular & Veri:The obtained data were evaluated statistically, and results with a value of p<0.05 were accepted assignificant.RESULTS: While no reduction was observed in the proliferation, the gene expression of intact intervertebral disc tissue cells wastime-dependently decreased compared to the control group, and these results were reported to be statistically significant.CONCLUSION: This study observed the effect that a pharmaceutical preparation, which was used on intervertebral disc tissuebefore and after the operation, had on normal, healthy, and intact tissue.
💡
Sonuç & Katkı:It concludes that alterations in the expression of genesinvolved in the anabolic and/or catabolic process, even in adjacent healthy tissue, may slow down the healing process of thedamaged tissue or cause undesired cell differentiation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
AIM: To evaluate the effects of pre- and intra-operatively administered daptomycin (DAP) on the intact human primary intervertebraldisc tissue cells.MATERIAL and METHODS: Primary cell cultures were established using tissues obtained through decompressive laminectomy,traumatic intervertebral disc herniation excision, and posterior transpedicular stabilization. Non-drug-administered samples wereused as a control group. The samples treated with DAP formed the study group. Molecular assays for proliferation and geneexpression were performed. The obtained data were evaluated statistically, and results with a value of p<0.05 were accepted assignificant.RESULTS: While no reduction was observed in the proliferation, the gene expression of intact intervertebral disc tissue cells wastime-dependently decreased compared to the control group, and these results were reported to be statistically significant.CONCLUSION: This study observed the effect that a pharmaceutical preparation, which was used on intervertebral disc tissuebefore and after the operation, had on normal, healthy, and intact tissue. It concludes that alterations in the expression of genesinvolved in the anabolic and/or catabolic process, even in adjacent healthy tissue, may slow down the healing process of thedamaged tissue or cause undesired cell differentiation.
🔖
Bu Makaleye Atıf Yap
KAPLAN, N., YILMAZ, İ., KARAARSLAN, N., SIRIN, D. Y., SIMSEK, A. T., CALISKAN, T., BİRCAN, R., ÖZBEK, H. (2019). Evaluation of the Effect of Daptomycin, a Glycopeptide Agent, on Intact Intervertebral Disc Tissue. Turkish Neurosurgery, Cilt: 29 - Sayı: 4, 522–529. https://ajindex.com/articles/405306
Akyuva Y, Kaplan N, Yilmaz I, Ozbek H, Sirin DY, Karaarslan N, Guler O, Ates O: Delivering growth factors through a polymeric scaffold to cell cultures containing both nucleus pulposus and annulus fibrosus. Turk Neurosur 2018 (Epub ahead of print
Antony SJ: Combination therapy with daptomycin, vancomycin, and rifampin for recurrent, severebone and prosthetic joint infections involving methicillin-resistant Staphylococcus aureus. Scand J Infect Dis 38: 293-295, 2006 3. Avery LM, Steed ME, Woodruff AE, Hasan M, Rybak MJ: Daptomycin-nonsusceptible vancomycin-intermediatest a phylococcusaureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dosedaptomycin and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother 56: 5990-5993, 2012 4. Back DA, Bormann N, Calafi A, Zech J, Garbe LA, Müller M, Willy C, Schmidmaier G, Wildemann B: Testing of antibiotic releasing implant coatings to fight bacteria in combatassociated osteomyelitis-an in-vitro study. Int Orthop 40: 1039-1047, 2016 5. Barreau S, Benaboud S, Kernéis S, Moachon L, Blanche P, Groh M, Massias L, Treluyer JM, Poyart C, Raymond J: Staphylococcus aureus osteo-articular infection: Usefulness of the determination of daptomycin serum concentration to explain a treatment failure. Int J Clin Pharmacol Ther 54:923- 927, 2016 6. Bionda N, Pitteloud JP, Cudic P: Cyclic lipodepsipeptides: A new class of antibacterial agents in the battle against resistant bacteria. Future Med Chem 5: 1311-1330, 2013 7. Burdette SD: Daptomycin for methicillin-resistant Staphylococcus aureus infections of the spine. Spine J 9:e5-8, 2009 8. Denetclaw TH, Suehiro I, Wang PK, Tolliver GL: Successful treatment of ventriculostomy-associated meningitis caused by multidrug resistant coagulase-negative Staphylococcus epidermidis using low-volume intrathecal daptomycin and loading strategy. Ann Pharmacother 48: 1376-1379, 2014 9. Dimovska-Gavrilovska A, Chaparoski A, Gavrilovski A, Milenkovikj Z: The importance of perioperative prophylaxis with cefuroxime or ceftriaxone in the surgical site infections prevention after cranial and spinal neurosurgical procedures. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 38:85-97, 2017 10. Dogan M, Isyar M, Yilmaz I, Bilir B, Sirin DY, Cakmak S, Mahirogullari M: Are the leading drugs against Staphylococcus aureus really toxic to cartilage? J Infect Public Health 9:251- 258, 2016 11. Durante-Mangoni E, Andini R, Parrella A, Mattucci I, Cavezza G, Senese A, Trojaniello C,